About PHARMADRUG INC. (LMLLF) data
Data as of August 14, 2026.
PHARMADRUG INC. (LMLLF) has 30.75K shares sold short as of the latest FINRA settlement report on August 14, 2026. Short interest has increased by 100.00% compared with the prior settlement. At the current average daily volume, covering all open short positions would take about 2.26 days (days to cover).
Recent LMLLF short interest history
| Settlement date | Short interest | Change | Days to cover |
|---|---|---|---|
| Aug 14, 2026 | 30,746 | 100.00% | 2.26 |
| May 29, 2026 | 23,026 | 139.16% | 1.00 |
| May 15, 2026 | 9,628 | -5.38% | 1.00 |
| Apr 30, 2026 | 10,175 | -11.79% | 1.00 |
| Apr 15, 2026 | 11,535 | 27.28% | 1.00 |
| Mar 31, 2026 | 9,063 | 0.00% | 1.00 |
| Mar 13, 2026 | 9,063 | 0.00% | 22.89 |
| Feb 27, 2026 | 9,063 | 0.00% | 1.00 |
| Feb 13, 2026 | 9,063 | 100.00% | 1.00 |
| Jan 15, 2026 | 15,040 | -16.38% | 2.24 |
| Dec 31, 2025 | 17,987 | 100.00% | 1.54 |
| Oct 31, 2025 | 6,437 | 100.00% | 1.00 |
Full history, charts, and borrow-fee detail are on the LMLLF short interest page.
Frequently asked questions
What is the current short interest in LMLLF?
As of the latest FINRA settlement dated August 14, 2026, LMLLF had approximately 30,746 shares sold short. Short interest data is reported by FINRA twice per month.
How much does it cost to short LMLLF?
The latest borrow fee (cost to borrow) for LMLLF is 0.25% per year, based on IBKR data. Fees can change throughout the trading day as shares are borrowed and returned.
What is the days to cover ratio for LMLLF?
Days to cover for LMLLF is approximately 2.26 days. This estimates how many trading days it would take short sellers to buy back all outstanding short shares at the current average daily volume.
Is LMLLF a short squeeze candidate?
A squeeze needs shorts that are hard to close. LMLLF trades about 13,630 shares a day and would take roughly 2.26 days to unwind current short positions, at a current borrow fee of 0.25%. Higher days-to-cover and a rising borrow fee together are the setup to watch; neither alone is enough.